AMP 2017 Molecular Genetic Pathology Review Course
June 1-4, 2017
DoubleTree by Hilton Hotel
Bethesda - Washington DC
AMA PRA Category 1 Credit(s) TM
This activity was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society for Clinical Pathology (ASCP) and the Association for Molecular Pathology. ASCP is accredited by the ACCME to provide continuing medical education for physicians.
The ASCP designates this LIVE educational activity for a maximum of 26 AMA PRA Category 1 Credit(s) TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The AMP 2017 MGP Review Course is approved by the American Board of Pathology for up to 15.25 SAM credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).
The objectives of the AMP 2017 MGP Review Course are:
The AMP 2017 MGP Review Course will be designed to meet the participants' education needs in the physician competency area of Medical Knowledge, as defined by the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties (ABMS), and to support participants' lifelong learning towards a goal of promoting patient safety and improving patient care. At the completion of this activity, participants should be able to discuss the research underway and/or current molecular approaches to the diagnosis and prognosis of inherited diseases (including Bayesian calculations, pharmacogenetics), molecular hematopathology (including clonality, translocations, and point mutations), cytogenetics, solid and soft tissue tumors, and molecular genetic testing of infectious diseases (including bacterial, fungal, viral, and parasitic pathogens) as well as DNA identity.
The AMP 2017 MGP Review Course is especially targeted to pathologists, geneticists, technical laboratory directors, molecular pathology laboratory personnel, and trainees who:
* DISCLAIMER: AMP makes no guarantee or assurances that completion of its courses or participation in any educational activity will in any manner ensure a passing score on any certification examination or activity post-test, or achievement of certification status. The AMP Molecular Genetic Pathology review course is an educational program provided by the Association for Molecular Pathology, (AMP) and is not sponsored or endorsed by the American Board of Pathology (ABP) or the American Board of Medical Genetics (ABMG).